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Summary 
The recently cloned interleukin 13 (IL-13) shares most investigated biological activities  on B 
lymphocytes and monocytes with IL-4. In this study we investigated for the first time the potential 
role of IL-13 in the regulation of the growth of hematopoietic progenitor cells. IL-13 enhanced 
stem cell factor (SCF)-induced proliferation of Lin-Sca-1 + bone marrow progenitor cells more 
potently than IL-4. The effect of IL-13 was purely synergistic,  since IL-13 alone stimulated no 
colony formation.  Single cell experiments suggested that the synergistic effect of IL-13  on 
Lin-Sca-1 + progenitors was directly mediated. In contrast, IL-13 had no synergistic  activity 
on SCF-induced proliferation of the more mature Lin-Sca-1- progenitor cells. Thus, the cloning 
frequency in response to SCF  +  IL-13 was at least 20-fold higher in the Lin-Sca-1 + than the 
Lin-Sca-1- progenitor cell population. Furthermore, IL-13 but not IL-4 synergistically enhanced 
colony formation of Lin-Sca-1 + progenitors in response to granulocyte/macrophage colony- 
stimulating factor (GM-CSF) (threefold), whereas both IL-4 and IL-13 enhanced G-CSF-induced 
colony formation (threefold), and neither of the two significantly affected CSF-1 and IL-3-induced 
proliferation.  Finally, whereas stimulation of Lin-Sca-1 + progenitors by SCF  +  G-CSF resulted 
in the formation of 90%  granulocytes, the addition of IL-13  resulted in the production of 
macrophages exclusively. This novel effect on differentiation was directly mediated, shared with 
IL-4, and could not be observed  on Lin-Sca-1-  progenitor cells. Collectively,  these findings 
indicate a novel role of IL-13 in early myelopoiesis, partially overlapping but also different from 
that of IL-4. 
H 
ematopoiesis is a lifelong process in which short-lived 
mature hematopoietic cells are continuously replenished 
by a pool of primitive pluripotent hematopoietic stem cells 
(1-3).  It seems that steady state hematopoiesis, where most 
stem cells reside in quiescence, is regulated at least in part 
by  the  opposing  actions  of  stimulatory  and  inhibitory 
cytokines. CSFs, which include G-CSF,  M-CSF or CSF-1, 
GM-CSF, and IL-3 or multi-CSF, are a unique family of he- 
matopoietic growth factors  (HGFs) 1 in that they can pro- 
mote the in vitro proliferation and granulocyte-macrophage 
differentiation of hematopoietic progenitor cells in the ab- 
sence of other HGFs (1, 4). In contrast, a number of other 
HGFs, including multiple interleukins and stem cell factor 
(SCF, also called kit ligand, steel factor, or mast cell growth 
factor) have little or no effect on the growth of hematopoi- 
1 Abbreviations used in thispapev. HGF, hematopoietic growth factor; rHu, 
recombinant  human; rMu, recombinant murine; rr, recombinant rat; SCF, 
stem cell factor. 
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etic progenitor cells when acting alone, but can synergisti- 
cally enhance their proliferative response to the CSFs and/or 
SCF (3, 5-14). Synergistic HGFs are of particular importance 
in the regulation of primitive hematopoietic progenitor cells, 
since they, in contrast to more mature progenitors, can only 
be triggered to proliferate  optimally as a result of synergy 
between multiple HGFs (13-16). 
IL-4, is one of many cytokines produced by activated T 
cells. It stimulates B cells (17, 18), T cells (19, 20), and mast 
cells (19, 20). Furthermore, it has been demonstrated to bi- 
functionally affect the in vitro growth of hematopoietic pro- 
genitor cells (21, 22).  IL-13  is another recently doned T 
cell-derived cytokine that shows homology with IL-4 (23, 
24).  IL-4  and IL-13  appear  to have  a common signaling 
receptor subunit, whereas they have separate ligand-binding 
subunits (25, 26). This probably explains why IL-4 and IL-13 
show overlapping but also distinctly different patterns of bi- 
ological activities  on investigated cell types (23-27). Thus, 
IL-13 but not IL-4 can stimulate IFN-3' synthesis by large 
University Press ￿9 0022-1007/94/07/0075/08  $2.00 granular lymphocytes (23), whereas PHA-activated PBMC 
proliferate in response to IL-4 but  not  IL-13  (25). 
Since the role of IL-13 in hematopoiesis has not yet been 
established,  we investigated whether IL-13 could affect the 
growth of mature as well as primitive murine hematopoietic 
progenitor cells, and to what extent its effects overlap with 
those of IL-4. 
Materials and Methods 
HGFs.  Recombinant human (rHu)IL-13 was purified from cul- 
ture supematants of stably transfected CHO cell lines as previously 
described (23).  Three different lots of rHulL-13 (1PE, 4PE, and 
6PE) were used in the present studies.  Purified recombinant mu- 
rine (rMu)Ib3 and IL-4 were purchased from Peprotech Inc. (Rocky 
Hill, NJ). Purified rHuG-CSF, rMuGM-CSF, and recombinant rat 
(rr)SCF were generously supplied by Drs. Ian K. McNiece, Thomas 
C. Boone, and Keith E. Langley (Amgen Corp., Thousand Oaks, 
CA). rHuCSF-1 was kindly provided by Dr. Michael Geier (Cetus 
Corp., Emeryville, CA). rHulb11 was a generous gift from Genetics 
Institute (Cambridge,  MA),  purified rHulL-ler  was  supplied  by 
Hoffmann-La Roche (Basel, Switzerland). Unless otherwise indi- 
cated, all growth factors were used at predetermined optimal con- 
centrations: rMuGM-CSF, 20 ng/ml; rHuG-C~F, 50 ng/ml; rMulL- 
3, 20 ng/ml; rHuCSF-1, 50 ng/ml; rrSCF, 100 ng/ml; rHulL-lot, 
20 ng/ml;  and rHulb11,  50 ng/ml. 
Isolation of Lin-Sca-1 + and Lin-Sca-1 - Bone Marrow Cells.  Lin- 
bone marrow cells were isolated from femurs of normal C57BL/6 
mice (5-8-wk-old), according to a previously described protocol 
(2).  Briefly, low density bone marrow cells were obtained using 
lymphocyte separation medium (Nycomed, Oslo, Norway). Cells 
were washed twice in IMDM (Gibco, Paisley, UK) and resuspended 
in IMDM supplemented with 20% FCS (Sera-Lab, Sussex, UK), 
100 U/ml penicillin,  and 3 mg/ml t-glutamine (complete IMDM). 
The cells were incubated at 4~  for 30 rain in a cocktail of  predeter- 
mined optimal concentrations of antibodies: RA3-6B2 (B220 an- 
tigen; PharMingen, San Diego, CA),  RB6-8C5 (GR-1 antigen; 
PharMingen), MAC-1 (Serotec,  Oxfordshire, UK), Lyt-2 (CDS; 
Beckton Dickinson & Co., Sunnyvale, CA), and L3T4 (CD4; Phar- 
Mingen). Cells were washed twice and resuspended in complete 
IMDM.  Sheep anti-rat  IgG (Fc)-conjugated immunomagnetic 
beads  (Dynal, Oslo, Norway) were added at a cell/bead ratio of 
1:20, and incubated at 4~  for 30 rain. Labeled (Lin +) cells were 
removed by a magnetic particle concentrator (Dynal), and Lin- 
cells recovered from the supernatant.  Lin-Sca-1 + cells were iso- 
lated as described by others (2, 28). Briefly, 4-6  x  107 Lin- cells 
were resuspended per milliliter of complete IMDM and incubated 
for 30 min on ice with either FITC-conjugated rat anti-mouse 
SCA-1  antibody  (cone E13167-7;  PharMingen)  or  an  isotype- 
matched  control  antibody.  The  cells  were washed  twice,  and 
Lin-Sca-1 + cells sorted on a cell sorter (Epics Elite; Coulter Elec- 
tronics, Hialeah, FL) equipped with a 488-nm tuned argon laser 
set to give a power of 15 mW, with a rate of 1,500-2,000 cells/s. 
Lin- cells falling into median right angle scatter and median to 
high forward scatter were analyzed for Sca-1 expression, and cells 
falling into both regions were selected. Light scatter was collected 
was collected through a 488-nm band pass filter and FITC fluores- 
cence was collected through a 488-nm-long pass filter and a 525- 
nm band pass filter.  The final recovery of Lin-Sca-1 + cells was 
0.05-0.1%  of the unfractionated bone marrow. In some experi- 
ments,  the remaining Lin-Sca-1-  cells were collected as well. 
Single Cell Proliferation Assay.  Lin-Sca-1 + or Lin-Sca-1- cells 
were seeded in microtiter plates  (Nunc, Kamstrup, Denmark) at 
a concentration of one cell per well in a volume of 20 #1 complete 
IMDM. Wells were scored for colony growth (>50 cells) and clusters 
(10-50 cells) after 12 d of incubation at 37~  and 5% COz in air. 
Cell Morphology.  Liu-Sca-1 + or Lin-Sca-1- cells were plated 
in complete IMDM and incubated for 12-14 d with predetermined 
optimal concentrations of cytokines at 37~  and 5% CO2 in air. 
Cell morphology was determined following Giemsa staining of 
cytospin preparations. 
Results 
IL-13  Enhances  SCF-induced  Colony  Formation  of Single 
Lin-Sca-1 + Progenitor but Not Lin-Sca-1-  Progenitor Cells. 
The infrequent  Lin-Sca-1 +  cells in  murine  bone marrow 
have been demonstrated  to be highly enriched in primitive 
hematopoietic progenitors. Thus, in agreement with others 
(2,  28), we have observed that  as few as  100 of these cells 
can rescue 50% of lethally irradiated mice (Veiby, O. P., un- 
published observations). In contrast, 3-4  x  104 unfraction- 
ated bone marrow cells are required to give the same degree 
of  protection  (29).  Furthermore,  Lin-Sca-1 +  cells  can 
efficiently long-term reconstitute all cell lineages of the blood 
(2, 28), and proliferate in vitro in response to defined HGFs 
(13,  14,  30,  31).  In  this  study,  Lin-Sca-1 +  cells  (300 per 
group) were plated individually to compare the direct effects 
of IL-13  and  IL-4  on  primitive bone  marrow  progenitor 
cells (Fig.  1).  Neither  rHulL-13  (1-500  ng/ml)  nor rMu 
IL-4 (1-500  ng/ml)  alone  stimulated  the  proliferation  of 
Lin-Sca-1 +  cells  cultured  individually  (Fig.  1).  Whereas 
G-CSF alone stimulated the formation of only two colonies 
of Lin-Sca-1 + cells it synergized with IL-13 as well as IL-4, 
resulting in the formation of 10 and 9 colonies, respectively. 
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Fsgure  1.  Effects  of Ib13  and  IL-4 on  the  proliferation of single 
Lin-Sca-1 + bone marrow progenitors. Lin-Sca-1 + bone marrow calls 
were isolated as described in Materials and Methods and plated at one call 
per well in 20 #1 complete IMDM supplemented  with predetermined op- 
timal concentrations ofcytokines as indicated. Wells  were scored  for colo- 
nies (>50 cells) after 12-14 d of incubation at 37~  and 5% COz in air 
in the absence or presence  of Ib13 (500 ng/ml) and IL-4 (100 ng/ml). The 
results represent the mean (SEM) of four separate experiments, with a 
minimum of 1,200 wells scored per group. (*) No colonies  were observed 
in the absence of growth factors or in the presence  of II:13 and IL-4 alone. 
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IL-13 enhanced CSF-1 and GM-CSF-induced colony forma- 
tion two- and three-fold, respectively (Fig.  1).  In contrast, 
neither  IL-13  nor  IL-4  significantly affected the  number 
of colonies formed by Lin-Sca-1 + progenitors in response 
to IL-3. 
In  agreement with previously published data SCF  (100 
ng/ml)  alone stimulated  some colony formation of single 
Lin-Sca-1 + cells  (13,  14),  and IL-4 (at 1-500 ng/ml) only 
marginally increased the number of SCF-responsive progen- 
itors (from 9 to 14 colonies; Fig.  1). In contrast, the addition 
of IL-13 (500 ng/ml) resulted in a sixfold increase in colony 
formation (from 9  to 53 colonies; Fig.  1).  In comparison, 
SCF  +  G-CSF,  a  very potent  proliferation  stimulus  for 
Lin-Sca-1 + progenitor cells  (13,  14),  stimulated the same 
number of colonies as SCF  +  IL-13, and the addition of IL- 
13 did not significantly enhance the SCF  +  G-CSF response 
(Fig.  1). The synergistic effect of IL-13 on SCF-stimulated 
proliferation occurred in a concentration-dependent fashion 
with an EDs0 of 50-100 ng/ml,  and maximum effect ob- 
served at 500 ng/ml (data not shown). The results described 
above were obtained using two different lots of  purified rHulL- 
13 (1PE and 4PE). In more recent experiments, using a third 
lot of rHulL-13 (6PE), we observed the same magnitude of 
synergy with G-CSF or GM-CSF, but no significant syn- 
ergy with CSF-1, and much less synergy with SCF (data not 
shown).  Specifically,  the 6PE lot of IL-13 enhanced SCF- 
induced colony formation 2.5-fold as compared with 6-fold 
with the two first lots of IL-13, and 1.5-fold with IL-4. In 
addition, whereas the first two lots of rHulL-13 also enhanced 
Table  1.  Effect of IL-I3 and IL-4 on the Myeloid Differentation 
of Lin-Sca-1 + Bone Marrow Cells 
Growth  Percent  Percent  Percent 
factors  blasts  granulocytes  macrophages 
SCF  4 (1)  90 (3)  6  (2) 
SCF  +  IL-13  4 (1)  89 (3)  S  (3) 
SCF  +  IL-4  4 (2)  85  (7)  11  (6) 
SCF  +  G-CSF  2 (1)  89 (3)  8  (4) 
SCF  +  G-CSF  +  IL-13  0 (0)  2 (1)  98  (1) 
SCF  +  G-CSF  +  IL-4  0 (1)  13 (5)  87  (6) 
SCF  +  IL-11  26 (4)  58 (7)  16  (7) 
SCF  +  IL-11  +  IL-13  8 (5)  9 (5)  81(11) 
SCF  +  IL-11  +  IL-4  5 (3)  12 (6)  83 (10) 
250 Lin-Sca-l+ cells were plated in 500 #1 complete IMDM in the 
presence of predetermined optimal concentrations of growth factors 
(Materials and Methods) as indicated, and in the absence  or presence  of 
IL-13 (100 ng/ml) or IL-4 (20 ng/ml). Cytospin  preparations were pre- 
pared and stained  with Giemsa staining (Sigma Chemical  Co., St. Louis, 
MO) after 14 d of incubation at 37~  and 5% COz in air. Cell mor- 
phology was determined  on at least 100 cells per group in each experi- 
ment. Results represent the mean (SEM) of four separate experiments. 
Figure 2.  The effects  of II~13 and IL-4 on the proliferation  of single 
Lin-Sca-1- bone marrow progenitors. Lin-Sca-1- bone marrow cells 
were isolated as described  in Materials and Methods and cultured at one 
cell per well in 20/~1 complete  IMDM in the absence of growth factors 
or supplemented  with predetermined  optimal  concentrations  of  SCF, G-CSF, 
and GM-CSF. A total of 300 wells were cultured  per group and colony 
growth (>50 cells) was determined  after 7 d of incubation at 37~  and 
5% CO2 in air in the absence or presence  of IL-13 (500 ng/ml) or IL-4 
(100 ng/ml). Results represent  the mean (SEM) of three separate experi- 
ments. No colony  formation  was observed  in the absence  of  growth  factors 
or in the presence of Ib13 or IL-4 alone. 
the size of the colonies formed in response to SCF, the 6PE 
lot had no such effect on the size of the SCF-responsiveness 
clones (data not  shown). 
The Lin-Sca-1- bone marrow cells which are depleted of 
the most primitive hematopoietic progenitors (2, 13, 28, 30), 
and which thus represent more mature progenitors, were next 
explored for the potential effects oflL-13. In accordance with 
others (30) these colonies appeared and disappeared earlier 
than the Lin-Sca-1 + progenitors.  Colonies were therefore 
scored after 7 d  (Fig. 2) as well as after 14 d of incubation 
(data not shown),  and although the colony numbers were 
slightly lower on day 14, the effects of IL-13 and IL-4 were 
similar on days  7  and  14 (data not shown).  As previously 
demonstrated (13),  few or no colonies were formed when 
Lin-Sca-1- progenitors were plated individually and stimu- 
lated by SCF or G-CSF alone (Fig.  2).  In contrast to the 
ability of IL-13  to  enhance  SCF-induced  proliferation of 
Lin-Sca-1 + progenitor cells,  IL-13 had no effect on SCF- 
stimulated  colony  formation  of  Lin-Sca-1-  progenitors 
(Fig.  2). However, both IL-4 and IL-13 synergistically en- 
hanced G-CSF-stimulated colony formation of Lin-Sca-1- 
progenitors, increasing the cloning frequency two- to three- 
fold. In agreement with previous studies (31-33), IL-4 in- 
hibited  GM-CSF-stimulated  colony  formation  of  single 
Lin-Sca-1- progenitors (from nine to five colonies; Fig.  2). 
In contrast to its potent synergistic effect on GM-CSF-stimu- 
lated proliferation of Lin- Sca-1 + progenitors, IL-13 had no 
effect or slightly inhibited GM-CSF-stimulated colony for- 
mation of Lin-Sca-1-  progenitors (Fig.  2).  The effects of 
IL-13 on colony formation of Lin-Sca-1-  progenitors did 
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shown). Thus, IL-13 differentially  regulates the proliferation 
of  primitive and more mature hematopoietic progenitor cells. 
IL-13 Blocks SCF + G-CSF-induced Granulocyte Differenti- 
ation of Lin-Sca-1 + Progeny, and Stimulates Exclusively  Mac- 
rophage Production.  Since  IL-13  potently enhanced  SCF- 
induced proliferation of Lin-Sca-1 + progenitors,  we next 
asked whether IL-13 also could affect the differentiation of 
SCF-stimulated Lin-Sca-1 + progeny cultured in liquid cul- 
ture. As previously demonstrated (12, 13), SCF alone stimu- 
lated the production of mature granulocytes almost exclu- 
sively  (90%;  Table  1).  In  addition,  a  low  number  of 
macrophages (6%) and blasts (4%) was observed.  Whereas 
IL-13 enhanced SCF-induced cell production (data not shown), 
it did not significantly affect the relative proportion of gran- 
ulocytes, macrophages, or blasts (Table 1).  Next, SCF was 
combined with G-CSF, a two-factor combination demon- 
strated to potently stimulate granulopoiesis of primitive he- 
matopoietic progenitors (12, 34). The addition of IL-13 did 
not significantly affect the number of cells produced in re- 
sponse to SCF +  G-CSF (data not shown). However, an al- 
most  complete  switch  from  granulocyte  to  macrophage 
production was observed in response to all three rHulL-13 
lots (Table 1 and Fig. 3).  The switch in differentiation was 
concentration dependent (Fig. 4), and was observed at lower 
concentrations of IL-13 than the synergistic effect on SCF- 
induced  proliferation  (EDs0 of  1-10  ng/ml  and  50-100 
ng/ml, respectively). 
SCF +  IL-11 is another growth factor combination demon- 
strated to potently stimulate granulocyte/macrophage produc- 
tion of primitive progenitors (8,  35).  As much as 26%  of 
SCF  +  IL-11-stimulated Lin-Sca-1 + progeny observed  in 
culture after 14  d  had the appearance  of blasts  (Table 1). 
Whereas IL-13 did not significantly affect the total cell produc- 
tion in response to SCF  +  IL-11  (data not shown), it re- 
duced the proportion of granulocytes from 58 to 9%, blasts 
from 26 to 8%, with a concomitant increase in macrophages 
(from 16 to 81%; Table 1). IL-13 also resulted in a dramatic 
shift toward macrophage production when combined with 
other potent granulocyte stimuli, such as SCF +  IL-1, SCF 
+  IL-6, or SCF  +  IL-12 (data not shown). Finally, IL-4 
showed comparable effects to IL-13 on the differentiation of 
Lin-Sca-1 + progeny (Table 1).  Thus, both IL-13  and IL-4 
can potently inhibit granulocyte differentiation and stimu- 
late macrophage differentiation of Lin-Sca-1 + progeny. 
To exclude the possibility of the stimulatory effect of IL-13 
on SCF  +  G-CSF-induced macrophage production being 
indirectly mediated through potentially contaminating ac- 
cessory  cells,  the  myeloid  differentiation  of  Lin-Sca-1 + 
progeny was  also  assessed by morphological examination 
of Lin-Sca-1 +  clones cultured and examined individually (Table 
Table  2.  Effects of IL-13  on the Morphology of sc~  + 
G-CSF-induced Colonies Derived  from  Single Lin-Sca-1 +Bone 
Marrow Progenitors 
Colony morphology 
Growth  Colonies/ 
factors  300 cells CFU-G CFU-M CFU-GM 
% 
SCF  +  G-CSF  62 (10)  49  8  43 
SCF  +  G-CSF  73  (15)  0  90  10 
+  IL-13 
Lin-Sca-1  + cells were plated at one cell per well in complete IMDM 
as described  in Materials and Methods,  and supplemented  with SCF (100 
ng/ml) and G-CSF (50 ng/ml). Cultures  were scored  for colony  growth 
after 14 d of incubation  at 37~  and 5% CO2, in the absence or presence 
of IL-13 (500 ng/ml). The number of colonies presented are the mean 
(SEM) from four separate experiments. Colony  morphology  was deter- 
mined after  Giemsa staining  of cytospin  preparations of individual  colo- 
nies. For both groups a total of at least 60 colonies was sampled from 
four separate experiments. 
2).  These experiments were  also  performed to  determine 
whether the observed increase in macrophage production was 
due to an absolute increase in progenitors producing exclu- 
sively macrophages (CFU-M).  SCF  +  G-CSF-stimulated 
proliferation of CFU-G was completely  blocked by IL-13 (100 
ng/ml)  and the number of CFU-GM inhibited by 80%, 
resulting in a more than eightfold increase in the number 
of CFU-M (Table 2). Furthermore, since the total number 
of colonies formed in response  to SCF  +  G-CSF was not 
significantly affected by IL-13 (Table 2), these findings demon- 
strated a potent absolute increase in the number of Lin-Sca-1 + 
progenitors producing exclusively macrophages. 
To examine the effects of IL-13 on the differentiation of 
more mature progenitors,  Lin-Sca-1-  bone marrow cells 
were next cultured in SCF  +  G-CSF in the presence or ab- 
sence of IL-13. Since the peak production of mature myeloid 
ceils from Lin-Sca-1-  cells was observed after 1 wk of in- 
cubation, and since most cells were dead by 2 wk (data not 
shown), cell morphology was examined on day 7 (Table 3). 
Furthermore, 20,000 SCF  +  G-CSF-stimulated Lin-Sca-1- 
as opposed to 250 Lin-Sca-1 + cells were required to gen- 
erate enough cells for cytospin preparations. Neither IL-13 
(500 ng/ml) nor IL-4 (20 ng/ml) affected the relative produc- 
tion of granulocytes and macrophages of Lin-Sca-1-  pro- 
genitors in response to SCF +  G-CSF (Table 3). Thus, IL-13 
(and IL-4) preferentially stimulates macrophage production 
of primitive murine bone marrow progenitor ceUs. 
Figure 3.  The effects  of IL-13 on differentiation  of Lin-Sca-1  + progeny.  250 Lin-Sca-1  § cells were plated in 500 ~1 complete  IMDM supplemented 
with G-CSF (50 ng/ml) and SCF (100 ng/ml), and cultured for 14 d in the absence (A) or presence (/3) of II.-13 (100 ng/ml). Cytospin  preparation 
were prepared and stained with Giemsa. x 1000. 
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Myeloid Differentiation  of Lin-Sca-I -  Progenitor  Cells 
Percent  Percent  Percent 
Growth  factors  blasts  granulocytes  rnacrophages 
SCF  +  G-CSF  3  (2)  92 (5)  6 (4) 
SCF  +  G-CSF  +  IL-13  6 (3)  87 (4)  7 (6) 
SCF  +  G-CSF  +  IL-4  5 (3)  94 (3)  5 (3) 
Lin-Sca-1- bone marrow cells were separated as described in Materials 
and  Methods and 20,000  ceils were plated in 500 #1 complete IMDM 
supplemented  with SCF (100 ng/ml) and  G-CSF (50 ng/ml) and cul- 
tured at 37~  and  5% CO2 in air in the absence or presence of IL-13 
(100 ng/ml) or IL-4 (20 ng/ml). After 7 d of incubation  cell morphology 
was determined on 100 cells per group after Giemsa staining  of cytospin 
preparations.  Results  represent  the mean  (SEM)  of three  separate  ex- 
periments. 
Discussion 
In recent years,  many synergistic growth factors capable 
of enhancing myelopoiesis of primitive hematopoietic pro- 
genitors have been identified and characterized, including IL-1, 
IL-6, IL-7, IL-11, and IL-12 (5-9). SCF, another synergistic 
HGF, has emerged as a key regulator of early hematopoiesis 
(10-14,  16, 35). SCF is unique in the sense that it can syner- 
gize with CSFs  as well as other synergistic HGFs  (10-14, 
16, 35).  Since it appears  that primitive hematopoietic pro- 
genitors require multiple stimulatory signals  to proliferate 
and  differentiate,  it  remains  important  to  identify HGFs 
that can synergize with SCF or CSFs to stimulate primitive 
hematopoietic  progenitor  cells.  This  study  revealed  that 
the newly cloned IL-13 can synergize with SCF as well as 
CSFs, increasing the number of colonies of SCF-stimulated 
Lin-Sca-1 + but not Lin-Sca-1- bone marrow progenitors. 
This suggests that IL-13 in this regard preferentially acts on 
primitive progenitors.  The fact that  the synergistic effects 
of IL-13 were observed at the single cell level suggests that 
its effects are directly mediated on the progenitors, although 
autocrine mechanisms cannot be excluded. The present view 
that IL-13 can stimulate normal bone marrow progenitor cells 
is not surprising in light of the observation that the premye- 
loid cell line TF-1 also proliferates in response to IL-13 (24). 
This is the first report demonstrating the effects of IL-13 
on hematopoiesis. Of particular interest was the finding that 
IL-13 showed a pattern of synergistic activity different from 
that of IL-4, since these two cytokines show homology and 
even share a receptor subunit thought to be essential in signal 
transduction (23-26). The fact that IL-13 more potently en- 
hanced SCF-induced proliferation of Lin- Sca-1  + progenitors 
than IL-4 could be explained by studies suggesting that the 
IL-4 and IL-13 receptor complexes use separate ligand binding 
proteins (25, 26).  It is therefore possible that more SCF-re- 
sponsive progenitors express the binding proteins of IL-13 
than those of IL-4, or alternatively that the progenitors ex- 
press higher levels of receptors for IL-13 than for IL-4. On 
the other hand, IL-13  and IL-4 were equally efficient in in- 
Figure  4.  The dose-response  of IL-13 on the differentiation  of SCF + 
G-CSF-stimulated Lin- Sca-1 + progenitor cells. 250 Lin- Sca-1 + bone 
marrow cells were plated  in 500/A complete IMDM in the presence of 
SCF (100 ng/ml) and G-CSF (50 ng/ml), and exposed to increasing con- 
centrations  of IL-D as indicated.  After 14 d of incubation  at 37~  and 
5% CO2 in air, cytospin preparations  were stained with Giemsa and cell 
morphology determined  on at least  100 cells per group in each experi- 
ment. Results  presented represent  the mean (SEM) of three  separate ex- 
periments.  (*) No granulocytes  were observed in the presence of IL-13 
100 and  500 ng/ml. 
ducing a switch in SCF  +  G-CSF-induced differentiation 
of Lin-Sca-1 + progeny  towards macrophages.  Thus,  this 
progenitor cell population would appear to have an expres- 
sion of both IL-4 and IL-13 receptors above the threshold 
needed to elicit the effect on differentiation. An alternative 
explanation could be the existence of a separate low affinity 
receptor for IL-13  distinct from that of IL-4, which could 
signal  the proliferative signal,  whereas the common high 
affinity  receptor  would  signal  the  differentiation  of the 
Lin-Sca-1 + progenitors. In fact,  such a distinct low affinity 
signal transducing receptor has been identified for IL-4 (36). 
The hematopoietic effects of two original lots of purified 
rHulL-13 (1PE and 4PE) used in the present studies, differed 
from a third lot in one important (quantitative) aspect, the 
magnitude of enhancement of SCF-stimulated proliferation 
of Lin-Sca-1 + progenitor cells. The other effects observed 
were similar between all three lots.  The difference between 
the two previous (1PE and 4PE) and most recent (6PE) lots 
of rHulL-13 is of particular interest, since all of them were 
purified according to the same procedure (23). Just recently 
we obtained a neutralizing antibody against IL-13 which ap- 
pears  to neutralize the effects of the new IL-13  lot (6PE), 
but only partially the enhancing effects of the two first IL-13 
lots (1PE and 4PE) on SCF-stimulated proliferation,  suggesting 
that the two first lots of IL-13 might contain contaminants 
capable of synergizing with SCF.  If so, it might reflect the 
unique  ability  of SCF  to  synergize with  numerous other 
cytokines to stimulate the growth of primitive progenitors 
(9-14). In addition, recent studies showing that very low levels 
of a cytokine are required to synergistically enhance the SCF 
response (37), in particular when multiple synergistic cytokines 
are acting in concert (like SCF and IL-13 here), suggest that 
such contaminating activities need only be present at very 
80  Novel Role of IL-13 in Hematopoiesis low  concentrations.  This  underscores  the  importance  of 
confirming novel effects obtained with even highly purified 
recombinant cytokines by the use of neutralizing antibodies, 
in particular  when looking  at  synergy with  SCF. 
Optimal enhancement of SCF-stimulated proliferation of 
Lin-Sca-1 +  progenitors  required  as  much  as  500  ng/ml 
rHulL-13, whereas the effects on differentiation  of Lin-Sca-1 + 
progeny were observed at lower concentrations of rHulL-13 
(10 ng/ml).  Other synergistic HGFs such as IL-6, IL-7, IL- 
12, and SCF are also required at high concentrations to op- 
timally stimulate the growth of primitive hematopoietic pro- 
genitor cells (7, 9, 12-14). The optimal concentration of SCF 
or IL-6 for colony formation is, for instance, 100-500 ng/ml 
(12-14). The rHu IL-13 used in this study is 60% identical 
to MulL-13 (23, 24), and MulL-13 and HulL-13 have similar 
specific  activity on human cells  (24).  Whereas  HulL-13 is 
active on murine cells as well, it has recently been observed 
that  HulL-13 is required  at approximately 100-fold higher 
concentrations than MulL-13 to stimulate proliferation of the 
mouse B9 plasmacytoma cell line (38). Thus, rHulL-13 might 
prove to be active on human hematopoietic progenitor cells 
at much lower concentrations  than  demonstrated  here. 
Whereas early acting synergistic HGFs such as IL-1, IL-6, 
IL-7, IL-11,  and IL-12 can potently enhance myelopoiesis of 
Lin-Sca-1 +  progenitor  cells  in  combination  with  SCF 
and/or CSFs (13,  14), they appear to have little or no effect 
on the relative production of granulocytes and macrophages 
(7, 9, 16, 30, 35). In contrast, here we demonstrate a unique 
ability of IL-13 in combination with SCF +  G-CSF to stimu- 
late only macrophage production of Lin-Sca-1 + progenitors, 
whereas predominantly  granulocytes were observed in the 
absence of IL-13. An IL-13-induced switch towards macro- 
phage production was also observed with other two-factor 
combinations that included SCF. Single clone experiments 
demonstrated that this potent effect of IL-13 on differentia- 
tion was directly mediated, and due to an absolute increase 
in the number of CFU-M and a concomitant reduction in 
CFU-G.  Not previously demonstrated,  IL-4 also preferen- 
tially stimulated macrophage production from Lin-Sca-1 + 
progenitors. Since IL-4 also has been shown to stimulate gran- 
ulocyte differentiation,  and inhibit macrophage production 
(32, 33, 39) of more mature progenitors, it appears that IL-4 
and IL-13 can bifunctionally modulate the myeloid differen- 
tiation of myeloid progenitors,  depending on the maturity 
of the targeted progenitors as well on as the specific growth 
factors stimulating growth. In this regard, it is worth noticing 
that the effects of IL-13 and IL-4 on differentiation were not 
observed on Lin-Sca-1-  progenitor  cells. 
In conclusion, IL-13 and IL-4 show overlapping but also 
different patterns of regulation of the proliferation  and differen- 
tiation of primitive murine hematopoietic progenitor cells. 
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